Startups
Brian Armstrong’s Human Life Extension Venture Raises Fresh Cash
This article is for subscribers only.
Brian Armstrong’s NewLimit, the longevity startup founded by the Coinbase Inc. executive that’s aiming to extend human life through reprogramming human genes, raised a new round of funding that values the company at $810 million.
NewLimit raised $130 million of a Series B round led by Kleiner Perkins, the epigenetics company said in a statement. The valuation was confirmed by a spokesperson.